Table 1: C urrent GLP-1 agonists, their site of action and their clinical indications The Faculty for Sexual and Reproductive Health (FSRH) have issued a statement of recommendations in January 2025 regarding patients of childbearing age taking GLP-1 agonists
By leveraging the physiological properties of GLP-1, she and her team developed a class of medicationsGLP-1 receptor agoniststhat effectively promote weight loss in individuals with obesity
MyStart Health Expands Telehealth Access to Compounded GLP-1 Weight Management Programs Ahead of Holiday Season as Americans Seek Medically-Supervised Solutions for 2025 Weight Loss Goals Delaware-Based Telehealth Platform Reports Increased Patient Interest in Cash-Pay Compounded Semaglutide and Tirzepatide Programs as Thanksgiving Week Signals Start of Annual Weight Loss Planning Season NEWARK, Nov
If you notice your mood shifts are lasting longer than expected or are particularly intense, talk to your doctor
More detail on adverse events, plus information on side effects and safety considerations, is provided below and summarized in Table 2
Wegovy treatment involves a dose-escalation schedule, starting at 0.25 mg once weekly and gradually increasing to the maintenance dose of 2.4 mg once weekly, as tolerated
